GRNA vs MGX

Comparison between GreenLight Biosciences Inc (GRNA, Company) and Metagenomi Inc (MGX, Company).

GRNA vs MGX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	GRNA(COMPANY)	MGX(COMPANY)
Market Cap	$45M	$45M
Max Drawdown	98.70%	90.69%
Sharpe Ratio	-1.27	0.08
5Y Beta	N/A	1.00
Industry	N/A	Biotechnology
P/E Ratio	-1.59	-0.53
PEG Ratio	N/A	-0.05
Debt to Equity	112.33%	0.00%
P/S Ratio	4.39	N/A
P/B Ratio	2.07	N/A

Market Cap

Winner

GRNA

$45M

MGX

$45M

Max Drawdown

GRNA

98.70%

Winner

MGX

90.69%

Sharpe Ratio

GRNA

-1.27

Winner

MGX

0.08

5Y Beta

GRNA

N/A

MGX

1.00

Industry

GRNA

N/A

MGX

Biotechnology

P/E Ratio

Winner

GRNA

-1.59

MGX

-0.53

PEG Ratio

GRNA

N/A

MGX

-0.05

Debt to Equity

GRNA

112.33%

Winner

MGX

0.00%

P/S Ratio

GRNA

4.39

MGX

N/A

P/B Ratio

GRNA

2.07

MGX

N/A

GRNA vs MGX - Historical Returns

Returns include dividend reinvestment.

Period	GRNA	MGX
1 month	+0.84%	-11.11%
3 months	+42.28%	-12.41%
6 months	-59.61%	-31.03%
1 year	-92.34%	-22.08%
Max(CAGR)	-89.56%	-59.63%

Winner

GRNA

+0.84%

MGX

-11.11%

Winner

GRNA

+42.28%

MGX

-12.41%

GRNA

-59.61%

Winner

MGX

-31.03%

GRNA

-92.34%

Winner

MGX

-22.08%

Max(CAGR)

GRNA

-89.56%

Winner

MGX

-59.63%

GRNA vs MGX - Annual Returns (2022 - 2026)

Returns include dividend reinvestment.

Year	GRNA	MGX
2026	N/A	-28.14%
2025	N/A	-57.26%
2024	N/A	-64.99%
2023	-73.96%	N/A
2022	-87.44%	N/A

GRNA vs MGX Drawdown Comparison

The maximum drawdown for GRNA was -98.70%, occurring on May 24, 2023. This drawdown has not yet recovered.

The maximum drawdown for MGX was -90.69%, occurring on Jun 16, 2026. This drawdown has not yet recovered.

The current GRNA drawdown is -97.79%. The current MGX drawdown is -90.20%.

Rank	GRNA	MGX
#1	-98.70% Mar 21, 2022 - May 24, 2023	-90.69% Feb 14, 2024 - Jun 16, 2026
#2	-47.65% Feb 3, 2022 - Mar 10, 2022	N/A
#3	-11.72% Mar 11, 2022 - Mar 15, 2022	N/A
#4	-0.30% Mar 15, 2022 - Mar 17, 2022	N/A